Antisense oligonucleotide (ASO) technology has accelerated drug discovery in the last few decades with several ASO-based drugs currently approved by FDA and many more being investigated in clinical ...

Non-small cell lung cancer ... effective in patients, this technology could be expanded to treat other cancers with known ...